RedHotStocks

Investors see the upside to Allergan deal, Bullish above $77

Long
NYSE:ABBV   AbbVie Inc.
As usual once a deal is announced the acquirers stock price automatically drops, then those that sold realise that the company knows more than them and the acquisition is actually beneficial, thus the price shoots back up. Currently old support is acting as resistance but we think not for long and a break above will be very positive in the near term, providing a nice long trade opportunity.
Alerts set for break of $77 in anticipation of strong move to $87 target.
Remember that Botox brings big $$$$$.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.